Management of the patient with resistant hypertension.
True refractory hypertension is relatively rare, but the causes of pseudoresistance are many. Thus, all patients should be considered medically treatable until proved otherwise. Initial workup should seek to determine whether the patient, the physician, or the hypertension is resistant. And one must make sure that therapy is indeed tailored to the patient's individual pathophysiology.
D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004347:Drug Interactions; D004351:Drug Resistance; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D010349:Patient Compliance; D012083:Renin / Q000097:blood; D013148:Spironolactone / Q000627:therapeutic use; D014655:Vascular Resistance
D000959:Antihypertensive Agents; D004232:Diuretics; D013148:Spironolactone; D012083:Renin